MedChem Partners LLC And Accendo Corporation Team Up To Offer Segmented Flow Chemistry

Online, November 9, 2011 (Newswire.com) - Medford, MA, and Tucson, AZ - MedChem Partners LLC and Accendo Corporation announced today a scientific collaboration focused on the development of new chemical methods on Accendo's Segmented Flow Reactor system. The use of flow reactor systems has been growing as it safely expands reaction conditions that enable the pursuit of new and greener chemistries. Accendo's segmented flow reactor technology goes beyond continuous flow reactors with extreme reaction conditions (300 °C pressures of up to 150 bar), significantly reduces the amount of experimental reaction materials and dramatically increases experimental throughput. Segmented flow allows for serial-parallel operation, which increases experimental throughput by as much as 10 times that of continuous flow.

In addition, segmented flow offers the added flexibility of scalability in the same reactor system. Thus using one system a researcher can run a series of reactions at milligram scale to determine the best procedure and then switch to batch mode and prepare 100's of grams of product using the optimized conditions. "This scientific collaboration with MedChem Partners is exciting as they will use the Propel Segmented Flow Chemistry system to develop new reaction methods while also showing the power of scalability." says Jan Hughes, president and CEO of Accendo.

As part of the collaboration, Accendo has installed their Propel Flow Reactor System into MedChem Partners Lexington, MA facility. MedChem Partners will use the Propel to more rapidly develop new, greener chemical reaction methods using less material than traditional batch methods. "We are really looking forward to adding this capability to allow our customers access to this exciting and innovative technology" said Steven Riesinger, co-Founder of MedChem Partners.